nodes	percent_of_prediction	percent_of_DWPC	metapath
Mifepristone—AR—hematologic cancer	0.153	0.499	CbGaD
Mifepristone—NR3C1—hematologic cancer	0.104	0.338	CbGaD
Mifepristone—ABCB1—hematologic cancer	0.05	0.163	CbGaD
Mifepristone—ABCC1—Idarubicin—hematologic cancer	0.0287	0.0613	CbGbCtD
Mifepristone—PGR—Betamethasone—hematologic cancer	0.0223	0.0476	CbGbCtD
Mifepristone—ABCC1—Daunorubicin—hematologic cancer	0.0203	0.0433	CbGbCtD
Mifepristone—NR3C1—Triamcinolone—hematologic cancer	0.0133	0.0284	CbGbCtD
Mifepristone—PGR—Dexamethasone—hematologic cancer	0.013	0.0277	CbGbCtD
Mifepristone—ABCC1—Mitoxantrone—hematologic cancer	0.0124	0.0263	CbGbCtD
Mifepristone—NR3C1—Betamethasone—hematologic cancer	0.0114	0.0243	CbGbCtD
Mifepristone—NR3C1—Prednisolone—hematologic cancer	0.0113	0.024	CbGbCtD
Mifepristone—NR3C1—Prednisone—hematologic cancer	0.0106	0.0227	CbGbCtD
Mifepristone—ABCC1—Epirubicin—hematologic cancer	0.01	0.0213	CbGbCtD
Mifepristone—ABCC1—Irinotecan—hematologic cancer	0.00973	0.0207	CbGbCtD
Mifepristone—ABCC1—Vinblastine—hematologic cancer	0.00865	0.0184	CbGbCtD
Mifepristone—ABCC1—Vincristine—hematologic cancer	0.00851	0.0181	CbGbCtD
Mifepristone—ABCB1—Lenalidomide—hematologic cancer	0.00837	0.0178	CbGbCtD
Mifepristone—CYP3A7—Ifosfamide—hematologic cancer	0.00806	0.0172	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Ifosfamide—hematologic cancer	0.00806	0.0172	CbGbCtD
Mifepristone—ABCC1—Etoposide—hematologic cancer	0.00779	0.0166	CbGbCtD
Mifepristone—CYP3A7—Imatinib—hematologic cancer	0.0077	0.0164	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Imatinib—hematologic cancer	0.0077	0.0164	CbGbCtD
Mifepristone—CYP3A5—Daunorubicin—hematologic cancer	0.00754	0.0161	CbGbCtD
Mifepristone—PGR—ovarian follicle—hematologic cancer	0.00749	0.355	CbGeAlD
Mifepristone—CYP2D6—Lomustine—hematologic cancer	0.00733	0.0156	CbGbCtD
Mifepristone—CYP3A5—Thalidomide—hematologic cancer	0.00687	0.0146	CbGbCtD
Mifepristone—NR3C1—Dexamethasone—hematologic cancer	0.00664	0.0141	CbGbCtD
Mifepristone—CYP3A5—Teniposide—hematologic cancer	0.00655	0.014	CbGbCtD
Mifepristone—CYP2D6—Idarubicin—hematologic cancer	0.00654	0.0139	CbGbCtD
Mifepristone—CYP3A5—Ifosfamide—hematologic cancer	0.00605	0.0129	CbGbCtD
Mifepristone—CYP3A5—Imatinib—hematologic cancer	0.00578	0.0123	CbGbCtD
Mifepristone—CYP2D6—Hydroxyurea—hematologic cancer	0.00556	0.0118	CbGbCtD
Mifepristone—ABCC1—Doxorubicin—hematologic cancer	0.00532	0.0113	CbGbCtD
Mifepristone—ABCC1—Methotrexate—hematologic cancer	0.00515	0.011	CbGbCtD
Mifepristone—CYP3A4—Bexarotene—hematologic cancer	0.00502	0.0107	CbGbCtD
Mifepristone—ABCB1—Daunorubicin—hematologic cancer	0.00491	0.0105	CbGbCtD
Mifepristone—CYP2D6—Bortezomib—hematologic cancer	0.00483	0.0103	CbGbCtD
Mifepristone—CYP3A7—Irinotecan—hematologic cancer	0.00481	0.0102	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Irinotecan—hematologic cancer	0.00481	0.0102	CbGbCtD
Mifepristone—ABCB1—Alitretinoin—hematologic cancer	0.00481	0.0102	CbGbCtD
Mifepristone—CYP3A4—Lomustine—hematologic cancer	0.00466	0.00994	CbGbCtD
Mifepristone—CYP3A4—Busulfan—hematologic cancer	0.00466	0.00994	CbGbCtD
Mifepristone—CYP3A5—Dasatinib—hematologic cancer	0.00464	0.00989	CbGbCtD
Mifepristone—CYP3A7—Vincristine—hematologic cancer	0.0042	0.00896	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Vincristine—hematologic cancer	0.0042	0.00896	CbGbCtD
Mifepristone—CYP3A4—Thiotepa—hematologic cancer	0.00416	0.00886	CbGbCtD
Mifepristone—ABCB1—Imatinib—hematologic cancer	0.00376	0.00801	CbGbCtD
Mifepristone—CYP3A5—Irinotecan—hematologic cancer	0.00361	0.00769	CbGbCtD
Mifepristone—CYP2D6—Imatinib—hematologic cancer	0.00354	0.00755	CbGbCtD
Mifepristone—ABCB1—Nilotinib—hematologic cancer	0.00342	0.00728	CbGbCtD
Mifepristone—ABCB1—Vinorelbine—hematologic cancer	0.00339	0.00722	CbGbCtD
Mifepristone—CYP3A4—Methoxsalen—hematologic cancer	0.00323	0.00689	CbGbCtD
Mifepristone—CYP2D6—Nilotinib—hematologic cancer	0.00322	0.00686	CbGbCtD
Mifepristone—CYP2D6—Vinorelbine—hematologic cancer	0.00319	0.0068	CbGbCtD
Mifepristone—CYP3A7—Dexamethasone—hematologic cancer	0.00317	0.00675	CbGbCtD
Mifepristone—CYP3A7-CYP3A51P—Dexamethasone—hematologic cancer	0.00317	0.00675	CbGbCtD
Mifepristone—CYP3A5—Vincristine—hematologic cancer	0.00315	0.00672	CbGbCtD
Mifepristone—CYP3A4—Bortezomib—hematologic cancer	0.00307	0.00655	CbGbCtD
Mifepristone—ABCB1—Dasatinib—hematologic cancer	0.00302	0.00643	CbGbCtD
Mifepristone—ABCB1—Mitoxantrone—hematologic cancer	0.00298	0.00635	CbGbCtD
Mifepristone—CYP3A4—Daunorubicin—hematologic cancer	0.00294	0.00627	CbGbCtD
Mifepristone—CYP3A5—Etoposide—hematologic cancer	0.00289	0.00616	CbGbCtD
Mifepristone—ABCB1—Betamethasone—hematologic cancer	0.00266	0.00566	CbGbCtD
Mifepristone—ABCB1—Gemcitabine—hematologic cancer	0.00263	0.00561	CbGbCtD
Mifepristone—ABCB1—Prednisolone—hematologic cancer	0.00262	0.00559	CbGbCtD
Mifepristone—CYP3A4—Cytarabine—hematologic cancer	0.00259	0.00553	CbGbCtD
Mifepristone—CYP3A4—Teniposide—hematologic cancer	0.00256	0.00544	CbGbCtD
Mifepristone—ABCB1—Prednisone—hematologic cancer	0.00248	0.00528	CbGbCtD
Mifepristone—CYP3A5—Dexamethasone—hematologic cancer	0.00238	0.00506	CbGbCtD
Mifepristone—CYP3A4—Ifosfamide—hematologic cancer	0.00236	0.00502	CbGbCtD
Mifepristone—ABCB1—Irinotecan—hematologic cancer	0.00235	0.005	CbGbCtD
Mifepristone—CYP3A4—Imatinib—hematologic cancer	0.00225	0.0048	CbGbCtD
Mifepristone—CYP3A4—Ruxolitinib—hematologic cancer	0.00212	0.00452	CbGbCtD
Mifepristone—ABCB1—Vinblastine—hematologic cancer	0.00209	0.00445	CbGbCtD
Mifepristone—ABCB1—Vincristine—hematologic cancer	0.00205	0.00437	CbGbCtD
Mifepristone—CYP3A4—Nilotinib—hematologic cancer	0.00205	0.00436	CbGbCtD
Mifepristone—CYP3A4—Vinorelbine—hematologic cancer	0.00203	0.00432	CbGbCtD
Mifepristone—CYP2D6—Vinblastine—hematologic cancer	0.00197	0.00419	CbGbCtD
Mifepristone—ABCB1—Cisplatin—hematologic cancer	0.00191	0.00408	CbGbCtD
Mifepristone—ABCB1—Etoposide—hematologic cancer	0.00188	0.00401	CbGbCtD
Mifepristone—CYP3A4—Triamcinolone—hematologic cancer	0.00186	0.00396	CbGbCtD
Mifepristone—CYP3A4—Dasatinib—hematologic cancer	0.00181	0.00385	CbGbCtD
Mifepristone—CYP3A4—Mitoxantrone—hematologic cancer	0.00179	0.00381	CbGbCtD
Mifepristone—CYP3A4—Betamethasone—hematologic cancer	0.00159	0.00339	CbGbCtD
Mifepristone—CYP3A4—Prednisolone—hematologic cancer	0.00157	0.00335	CbGbCtD
Mifepristone—ABCB1—Dexamethasone—hematologic cancer	0.00155	0.00329	CbGbCtD
Mifepristone—CYP3A4—Prednisone—hematologic cancer	0.00148	0.00316	CbGbCtD
Mifepristone—CYP2D6—Dexamethasone—hematologic cancer	0.00146	0.0031	CbGbCtD
Mifepristone—CYP3A4—Irinotecan—hematologic cancer	0.00141	0.003	CbGbCtD
Mifepristone—ABCB1—Doxorubicin—hematologic cancer	0.00128	0.00273	CbGbCtD
Mifepristone—CYP3A4—Vinblastine—hematologic cancer	0.00125	0.00267	CbGbCtD
Mifepristone—ABCB1—Methotrexate—hematologic cancer	0.00124	0.00265	CbGbCtD
Mifepristone—CYP3A4—Vincristine—hematologic cancer	0.00123	0.00262	CbGbCtD
Mifepristone—CYP2D6—Doxorubicin—hematologic cancer	0.00121	0.00258	CbGbCtD
Mifepristone—CYP3A4—Etoposide—hematologic cancer	0.00113	0.0024	CbGbCtD
Mifepristone—CYP3A4—Dexamethasone—hematologic cancer	0.000926	0.00197	CbGbCtD
Mifepristone—PGR—hematopoietic system—hematologic cancer	0.000904	0.0429	CbGeAlD
Mifepristone—CYP3A4—Doxorubicin—hematologic cancer	0.000769	0.00164	CbGbCtD
Mifepristone—AR—hematopoietic system—hematologic cancer	0.00072	0.0342	CbGeAlD
Mifepristone—PGR—blood—hematologic cancer	0.000599	0.0284	CbGeAlD
Mifepristone—AR—gonad—hematologic cancer	0.000548	0.026	CbGeAlD
Mifepristone—CYP3A5—hematopoietic system—hematologic cancer	0.000526	0.0249	CbGeAlD
Mifepristone—PGR—lung—hematologic cancer	0.000525	0.0249	CbGeAlD
Mifepristone—NR3C1—hematopoietic system—hematologic cancer	0.000522	0.0247	CbGeAlD
Mifepristone—PGR—testis—hematologic cancer	0.000495	0.0235	CbGeAlD
Mifepristone—AR—blood—hematologic cancer	0.000477	0.0226	CbGeAlD
Mifepristone—ABCC1—blood—hematologic cancer	0.000453	0.0215	CbGeAlD
Mifepristone—AR—lung—hematologic cancer	0.000418	0.0198	CbGeAlD
Mifepristone—ABCC1—lung—hematologic cancer	0.000397	0.0188	CbGeAlD
Mifepristone—NR3C1—gonad—hematologic cancer	0.000397	0.0188	CbGeAlD
Mifepristone—AR—testis—hematologic cancer	0.000395	0.0187	CbGeAlD
Mifepristone—CYP3A4—hematopoietic system—hematologic cancer	0.000395	0.0187	CbGeAlD
Mifepristone—CYP2D6—hematopoietic system—hematologic cancer	0.000388	0.0184	CbGeAlD
Mifepristone—ABCC1—testis—hematologic cancer	0.000375	0.0178	CbGeAlD
Mifepristone—PGR—lymph node—hematologic cancer	0.000359	0.017	CbGeAlD
Mifepristone—CYP3A5—blood—hematologic cancer	0.000348	0.0165	CbGeAlD
Mifepristone—NR3C1—blood—hematologic cancer	0.000346	0.0164	CbGeAlD
Mifepristone—NR3C1—bone marrow—hematologic cancer	0.000334	0.0159	CbGeAlD
Mifepristone—CYP3A5—lung—hematologic cancer	0.000305	0.0145	CbGeAlD
Mifepristone—NR3C1—lung—hematologic cancer	0.000303	0.0144	CbGeAlD
Mifepristone—AR—lymph node—hematologic cancer	0.000286	0.0136	CbGeAlD
Mifepristone—NR3C1—testis—hematologic cancer	0.000286	0.0136	CbGeAlD
Mifepristone—ABCB1—hematopoietic system—hematologic cancer	0.000279	0.0132	CbGeAlD
Mifepristone—ABCC1—lymph node—hematologic cancer	0.000272	0.0129	CbGeAlD
Mifepristone—CYP3A4—blood—hematologic cancer	0.000261	0.0124	CbGeAlD
Mifepristone—CYP2D6—blood—hematologic cancer	0.000257	0.0122	CbGeAlD
Mifepristone—CYP2D6—testis—hematologic cancer	0.000213	0.0101	CbGeAlD
Mifepristone—ABCB1—gonad—hematologic cancer	0.000212	0.0101	CbGeAlD
Mifepristone—NR3C1—lymph node—hematologic cancer	0.000207	0.00983	CbGeAlD
Mifepristone—ABCB1—blood—hematologic cancer	0.000185	0.00878	CbGeAlD
Mifepristone—ABCB1—bone marrow—hematologic cancer	0.000179	0.00849	CbGeAlD
Mifepristone—ABCB1—lung—hematologic cancer	0.000162	0.00769	CbGeAlD
Mifepristone—ABCB1—testis—hematologic cancer	0.000153	0.00726	CbGeAlD
Mifepristone—ABCB1—lymph node—hematologic cancer	0.000111	0.00526	CbGeAlD
Mifepristone—Dermatitis—Mitoxantrone—hematologic cancer	2.96e-05	0.000211	CcSEcCtD
Mifepristone—Dermatitis—Irinotecan—hematologic cancer	2.96e-05	0.000211	CcSEcCtD
Mifepristone—Chills—Methotrexate—hematologic cancer	2.95e-05	0.000211	CcSEcCtD
Mifepristone—Headache—Irinotecan—hematologic cancer	2.94e-05	0.00021	CcSEcCtD
Mifepristone—Headache—Mitoxantrone—hematologic cancer	2.94e-05	0.00021	CcSEcCtD
Mifepristone—Nausea—Ifosfamide—hematologic cancer	2.93e-05	0.000209	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Betamethasone—hematologic cancer	2.93e-05	0.000209	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Dexamethasone—hematologic cancer	2.93e-05	0.000209	CcSEcCtD
Mifepristone—Arthralgia—Prednisone—hematologic cancer	2.92e-05	0.000208	CcSEcCtD
Mifepristone—Myalgia—Prednisone—hematologic cancer	2.92e-05	0.000208	CcSEcCtD
Mifepristone—Feeling abnormal—Triamcinolone—hematologic cancer	2.92e-05	0.000208	CcSEcCtD
Mifepristone—Diarrhoea—Cisplatin—hematologic cancer	2.91e-05	0.000208	CcSEcCtD
Mifepristone—Anxiety—Prednisone—hematologic cancer	2.91e-05	0.000207	CcSEcCtD
Mifepristone—Vomiting—Gemcitabine—hematologic cancer	2.91e-05	0.000207	CcSEcCtD
Mifepristone—Insomnia—Dexamethasone—hematologic cancer	2.9e-05	0.000207	CcSEcCtD
Mifepristone—Insomnia—Betamethasone—hematologic cancer	2.9e-05	0.000207	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—hematologic cancer	2.9e-05	0.000207	CcSEcCtD
Mifepristone—Discomfort—Prednisone—hematologic cancer	2.88e-05	0.000206	CcSEcCtD
Mifepristone—Mental disorder—Methotrexate—hematologic cancer	2.88e-05	0.000206	CcSEcCtD
Mifepristone—Rash—Gemcitabine—hematologic cancer	2.88e-05	0.000206	CcSEcCtD
Mifepristone—Dermatitis—Gemcitabine—hematologic cancer	2.88e-05	0.000205	CcSEcCtD
Mifepristone—Hypersensitivity—Etoposide—hematologic cancer	2.87e-05	0.000205	CcSEcCtD
Mifepristone—Malnutrition—Methotrexate—hematologic cancer	2.86e-05	0.000204	CcSEcCtD
Mifepristone—Haemoglobin—Doxorubicin—hematologic cancer	2.86e-05	0.000204	CcSEcCtD
Mifepristone—Headache—Gemcitabine—hematologic cancer	2.86e-05	0.000204	CcSEcCtD
Mifepristone—Nausea—Vincristine—hematologic cancer	2.86e-05	0.000204	CcSEcCtD
Mifepristone—Haemorrhage—Doxorubicin—hematologic cancer	2.85e-05	0.000203	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisolone—hematologic cancer	2.84e-05	0.000202	CcSEcCtD
Mifepristone—Urticaria—Triamcinolone—hematologic cancer	2.81e-05	0.000201	CcSEcCtD
Mifepristone—Oedema peripheral—Doxorubicin—hematologic cancer	2.81e-05	0.0002	CcSEcCtD
Mifepristone—Asthenia—Etoposide—hematologic cancer	2.8e-05	0.0002	CcSEcCtD
Mifepristone—Connective tissue disorder—Doxorubicin—hematologic cancer	2.8e-05	0.0002	CcSEcCtD
Mifepristone—Body temperature increased—Triamcinolone—hematologic cancer	2.8e-05	0.0002	CcSEcCtD
Mifepristone—Oedema—Prednisone—hematologic cancer	2.8e-05	0.0002	CcSEcCtD
Mifepristone—Angiopathy—Epirubicin—hematologic cancer	2.79e-05	0.000199	CcSEcCtD
Mifepristone—Decreased appetite—Betamethasone—hematologic cancer	2.79e-05	0.000199	CcSEcCtD
Mifepristone—Decreased appetite—Dexamethasone—hematologic cancer	2.79e-05	0.000199	CcSEcCtD
Mifepristone—Nausea—Irinotecan—hematologic cancer	2.79e-05	0.000199	CcSEcCtD
Mifepristone—Nausea—Mitoxantrone—hematologic cancer	2.79e-05	0.000199	CcSEcCtD
Mifepristone—Infection—Prednisone—hematologic cancer	2.78e-05	0.000198	CcSEcCtD
Mifepristone—Mediastinal disorder—Epirubicin—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Betamethasone—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Dexamethasone—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Back pain—Methotrexate—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Fatigue—Dexamethasone—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Fatigue—Betamethasone—hematologic cancer	2.77e-05	0.000198	CcSEcCtD
Mifepristone—Chills—Epirubicin—hematologic cancer	2.76e-05	0.000197	CcSEcCtD
Mifepristone—Pruritus—Etoposide—hematologic cancer	2.76e-05	0.000197	CcSEcCtD
Mifepristone—Pain—Dexamethasone—hematologic cancer	2.75e-05	0.000196	CcSEcCtD
Mifepristone—Pain—Betamethasone—hematologic cancer	2.75e-05	0.000196	CcSEcCtD
Mifepristone—Nervous system disorder—Prednisone—hematologic cancer	2.74e-05	0.000196	CcSEcCtD
Mifepristone—Skin disorder—Prednisone—hematologic cancer	2.72e-05	0.000194	CcSEcCtD
Mifepristone—Nausea—Gemcitabine—hematologic cancer	2.71e-05	0.000194	CcSEcCtD
Mifepristone—Vomiting—Cisplatin—hematologic cancer	2.71e-05	0.000193	CcSEcCtD
Mifepristone—Mental disorder—Epirubicin—hematologic cancer	2.7e-05	0.000192	CcSEcCtD
Mifepristone—Rash—Cisplatin—hematologic cancer	2.69e-05	0.000192	CcSEcCtD
Mifepristone—Dermatitis—Cisplatin—hematologic cancer	2.68e-05	0.000191	CcSEcCtD
Mifepristone—Malnutrition—Epirubicin—hematologic cancer	2.68e-05	0.000191	CcSEcCtD
Mifepristone—Diarrhoea—Etoposide—hematologic cancer	2.67e-05	0.00019	CcSEcCtD
Mifepristone—Anorexia—Prednisone—hematologic cancer	2.67e-05	0.00019	CcSEcCtD
Mifepristone—Ill-defined disorder—Methotrexate—hematologic cancer	2.66e-05	0.00019	CcSEcCtD
Mifepristone—Feeling abnormal—Dexamethasone—hematologic cancer	2.65e-05	0.000189	CcSEcCtD
Mifepristone—Feeling abnormal—Betamethasone—hematologic cancer	2.65e-05	0.000189	CcSEcCtD
Mifepristone—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.63e-05	0.000187	CcSEcCtD
Mifepristone—Gastrointestinal pain—Betamethasone—hematologic cancer	2.63e-05	0.000187	CcSEcCtD
Mifepristone—Hypersensitivity—Triamcinolone—hematologic cancer	2.61e-05	0.000186	CcSEcCtD
Mifepristone—Back pain—Epirubicin—hematologic cancer	2.59e-05	0.000185	CcSEcCtD
Mifepristone—Angiopathy—Doxorubicin—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Mifepristone—Malaise—Methotrexate—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Mifepristone—Dizziness—Etoposide—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Mifepristone—Muscle spasms—Epirubicin—hematologic cancer	2.58e-05	0.000184	CcSEcCtD
Mifepristone—Mediastinal disorder—Doxorubicin—hematologic cancer	2.57e-05	0.000183	CcSEcCtD
Mifepristone—Chills—Doxorubicin—hematologic cancer	2.56e-05	0.000182	CcSEcCtD
Mifepristone—Urticaria—Dexamethasone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Mifepristone—Urticaria—Betamethasone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Mifepristone—Dizziness—Prednisolone—hematologic cancer	2.55e-05	0.000182	CcSEcCtD
Mifepristone—Asthenia—Triamcinolone—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Mifepristone—Abdominal pain—Betamethasone—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Mifepristone—Abdominal pain—Dexamethasone—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Mifepristone—Body temperature increased—Dexamethasone—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Mifepristone—Body temperature increased—Betamethasone—hematologic cancer	2.54e-05	0.000181	CcSEcCtD
Mifepristone—Nausea—Cisplatin—hematologic cancer	2.53e-05	0.00018	CcSEcCtD
Mifepristone—Insomnia—Prednisone—hematologic cancer	2.53e-05	0.00018	CcSEcCtD
Mifepristone—Pruritus—Triamcinolone—hematologic cancer	2.5e-05	0.000179	CcSEcCtD
Mifepristone—Mental disorder—Doxorubicin—hematologic cancer	2.5e-05	0.000178	CcSEcCtD
Mifepristone—Ill-defined disorder—Epirubicin—hematologic cancer	2.49e-05	0.000177	CcSEcCtD
Mifepristone—Vomiting—Etoposide—hematologic cancer	2.48e-05	0.000177	CcSEcCtD
Mifepristone—Malnutrition—Doxorubicin—hematologic cancer	2.48e-05	0.000177	CcSEcCtD
Mifepristone—Rash—Etoposide—hematologic cancer	2.46e-05	0.000176	CcSEcCtD
Mifepristone—Dermatitis—Etoposide—hematologic cancer	2.46e-05	0.000175	CcSEcCtD
Mifepristone—Headache—Etoposide—hematologic cancer	2.44e-05	0.000174	CcSEcCtD
Mifepristone—Arthralgia—Methotrexate—hematologic cancer	2.44e-05	0.000174	CcSEcCtD
Mifepristone—Myalgia—Methotrexate—hematologic cancer	2.44e-05	0.000174	CcSEcCtD
Mifepristone—Decreased appetite—Prednisone—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Mifepristone—Rash—Prednisolone—hematologic cancer	2.43e-05	0.000173	CcSEcCtD
Mifepristone—Dermatitis—Prednisolone—hematologic cancer	2.42e-05	0.000173	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.42e-05	0.000173	CcSEcCtD
Mifepristone—Malaise—Epirubicin—hematologic cancer	2.42e-05	0.000172	CcSEcCtD
Mifepristone—Fatigue—Prednisone—hematologic cancer	2.41e-05	0.000172	CcSEcCtD
Mifepristone—Headache—Prednisolone—hematologic cancer	2.41e-05	0.000172	CcSEcCtD
Mifepristone—Discomfort—Methotrexate—hematologic cancer	2.41e-05	0.000172	CcSEcCtD
Mifepristone—Back pain—Doxorubicin—hematologic cancer	2.4e-05	0.000171	CcSEcCtD
Mifepristone—Constipation—Prednisone—hematologic cancer	2.39e-05	0.000171	CcSEcCtD
Mifepristone—Muscle spasms—Doxorubicin—hematologic cancer	2.38e-05	0.00017	CcSEcCtD
Mifepristone—Dizziness—Triamcinolone—hematologic cancer	2.34e-05	0.000167	CcSEcCtD
Mifepristone—Infection—Methotrexate—hematologic cancer	2.32e-05	0.000166	CcSEcCtD
Mifepristone—Nausea—Etoposide—hematologic cancer	2.32e-05	0.000165	CcSEcCtD
Mifepristone—Hypertension—Epirubicin—hematologic cancer	2.31e-05	0.000165	CcSEcCtD
Mifepristone—Feeling abnormal—Prednisone—hematologic cancer	2.3e-05	0.000164	CcSEcCtD
Mifepristone—Asthenia—Betamethasone—hematologic cancer	2.3e-05	0.000164	CcSEcCtD
Mifepristone—Asthenia—Dexamethasone—hematologic cancer	2.3e-05	0.000164	CcSEcCtD
Mifepristone—Ill-defined disorder—Doxorubicin—hematologic cancer	2.3e-05	0.000164	CcSEcCtD
Mifepristone—Nervous system disorder—Methotrexate—hematologic cancer	2.29e-05	0.000164	CcSEcCtD
Mifepristone—Gastrointestinal pain—Prednisone—hematologic cancer	2.29e-05	0.000163	CcSEcCtD
Mifepristone—Nausea—Prednisolone—hematologic cancer	2.29e-05	0.000163	CcSEcCtD
Mifepristone—Myalgia—Epirubicin—hematologic cancer	2.28e-05	0.000163	CcSEcCtD
Mifepristone—Arthralgia—Epirubicin—hematologic cancer	2.28e-05	0.000163	CcSEcCtD
Mifepristone—Anxiety—Epirubicin—hematologic cancer	2.27e-05	0.000162	CcSEcCtD
Mifepristone—Pruritus—Betamethasone—hematologic cancer	2.27e-05	0.000162	CcSEcCtD
Mifepristone—Pruritus—Dexamethasone—hematologic cancer	2.27e-05	0.000162	CcSEcCtD
Mifepristone—Skin disorder—Methotrexate—hematologic cancer	2.27e-05	0.000162	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.27e-05	0.000162	CcSEcCtD
Mifepristone—Discomfort—Epirubicin—hematologic cancer	2.25e-05	0.000161	CcSEcCtD
Mifepristone—Vomiting—Triamcinolone—hematologic cancer	2.25e-05	0.000161	CcSEcCtD
Mifepristone—Malaise—Doxorubicin—hematologic cancer	2.24e-05	0.00016	CcSEcCtD
Mifepristone—Rash—Triamcinolone—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Mifepristone—Dry mouth—Epirubicin—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Mifepristone—Dermatitis—Triamcinolone—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Mifepristone—Anorexia—Methotrexate—hematologic cancer	2.23e-05	0.000159	CcSEcCtD
Mifepristone—Urticaria—Prednisone—hematologic cancer	2.22e-05	0.000158	CcSEcCtD
Mifepristone—Headache—Triamcinolone—hematologic cancer	2.22e-05	0.000158	CcSEcCtD
Mifepristone—Abdominal pain—Prednisone—hematologic cancer	2.21e-05	0.000158	CcSEcCtD
Mifepristone—Body temperature increased—Prednisone—hematologic cancer	2.21e-05	0.000158	CcSEcCtD
Mifepristone—Diarrhoea—Betamethasone—hematologic cancer	2.2e-05	0.000157	CcSEcCtD
Mifepristone—Diarrhoea—Dexamethasone—hematologic cancer	2.2e-05	0.000157	CcSEcCtD
Mifepristone—Oedema—Epirubicin—hematologic cancer	2.19e-05	0.000156	CcSEcCtD
Mifepristone—Hypotension—Methotrexate—hematologic cancer	2.18e-05	0.000156	CcSEcCtD
Mifepristone—Infection—Epirubicin—hematologic cancer	2.17e-05	0.000155	CcSEcCtD
Mifepristone—Nervous system disorder—Epirubicin—hematologic cancer	2.15e-05	0.000153	CcSEcCtD
Mifepristone—Hypertension—Doxorubicin—hematologic cancer	2.14e-05	0.000153	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.13e-05	0.000152	CcSEcCtD
Mifepristone—Skin disorder—Epirubicin—hematologic cancer	2.12e-05	0.000152	CcSEcCtD
Mifepristone—Dizziness—Dexamethasone—hematologic cancer	2.12e-05	0.000151	CcSEcCtD
Mifepristone—Dizziness—Betamethasone—hematologic cancer	2.12e-05	0.000151	CcSEcCtD
Mifepristone—Insomnia—Methotrexate—hematologic cancer	2.11e-05	0.000151	CcSEcCtD
Mifepristone—Myalgia—Doxorubicin—hematologic cancer	2.11e-05	0.000151	CcSEcCtD
Mifepristone—Arthralgia—Doxorubicin—hematologic cancer	2.11e-05	0.000151	CcSEcCtD
Mifepristone—Anxiety—Doxorubicin—hematologic cancer	2.1e-05	0.00015	CcSEcCtD
Mifepristone—Nausea—Triamcinolone—hematologic cancer	2.1e-05	0.00015	CcSEcCtD
Mifepristone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	2.1e-05	0.00015	CcSEcCtD
Mifepristone—Discomfort—Doxorubicin—hematologic cancer	2.09e-05	0.000149	CcSEcCtD
Mifepristone—Anorexia—Epirubicin—hematologic cancer	2.09e-05	0.000149	CcSEcCtD
Mifepristone—Dyspnoea—Methotrexate—hematologic cancer	2.08e-05	0.000149	CcSEcCtD
Mifepristone—Somnolence—Methotrexate—hematologic cancer	2.08e-05	0.000148	CcSEcCtD
Mifepristone—Dry mouth—Doxorubicin—hematologic cancer	2.06e-05	0.000147	CcSEcCtD
Mifepristone—Hypersensitivity—Prednisone—hematologic cancer	2.06e-05	0.000147	CcSEcCtD
Mifepristone—Hypotension—Epirubicin—hematologic cancer	2.04e-05	0.000146	CcSEcCtD
Mifepristone—Vomiting—Dexamethasone—hematologic cancer	2.04e-05	0.000146	CcSEcCtD
Mifepristone—Vomiting—Betamethasone—hematologic cancer	2.04e-05	0.000146	CcSEcCtD
Mifepristone—Decreased appetite—Methotrexate—hematologic cancer	2.03e-05	0.000145	CcSEcCtD
Mifepristone—Rash—Betamethasone—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Rash—Dexamethasone—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Oedema—Doxorubicin—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Dermatitis—Betamethasone—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Dermatitis—Dexamethasone—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Methotrexate—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Fatigue—Methotrexate—hematologic cancer	2.02e-05	0.000144	CcSEcCtD
Mifepristone—Headache—Dexamethasone—hematologic cancer	2.01e-05	0.000144	CcSEcCtD
Mifepristone—Headache—Betamethasone—hematologic cancer	2.01e-05	0.000144	CcSEcCtD
Mifepristone—Infection—Doxorubicin—hematologic cancer	2.01e-05	0.000143	CcSEcCtD
Mifepristone—Asthenia—Prednisone—hematologic cancer	2.01e-05	0.000143	CcSEcCtD
Mifepristone—Pain—Methotrexate—hematologic cancer	2e-05	0.000143	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.99e-05	0.000142	CcSEcCtD
Mifepristone—Nervous system disorder—Doxorubicin—hematologic cancer	1.98e-05	0.000142	CcSEcCtD
Mifepristone—Pruritus—Prednisone—hematologic cancer	1.98e-05	0.000141	CcSEcCtD
Mifepristone—Insomnia—Epirubicin—hematologic cancer	1.98e-05	0.000141	CcSEcCtD
Mifepristone—Skin disorder—Doxorubicin—hematologic cancer	1.97e-05	0.00014	CcSEcCtD
Mifepristone—Dyspnoea—Epirubicin—hematologic cancer	1.95e-05	0.000139	CcSEcCtD
Mifepristone—Somnolence—Epirubicin—hematologic cancer	1.94e-05	0.000139	CcSEcCtD
Mifepristone—Anorexia—Doxorubicin—hematologic cancer	1.93e-05	0.000138	CcSEcCtD
Mifepristone—Feeling abnormal—Methotrexate—hematologic cancer	1.93e-05	0.000137	CcSEcCtD
Mifepristone—Diarrhoea—Prednisone—hematologic cancer	1.91e-05	0.000137	CcSEcCtD
Mifepristone—Gastrointestinal pain—Methotrexate—hematologic cancer	1.91e-05	0.000136	CcSEcCtD
Mifepristone—Nausea—Dexamethasone—hematologic cancer	1.91e-05	0.000136	CcSEcCtD
Mifepristone—Nausea—Betamethasone—hematologic cancer	1.91e-05	0.000136	CcSEcCtD
Mifepristone—Decreased appetite—Epirubicin—hematologic cancer	1.9e-05	0.000136	CcSEcCtD
Mifepristone—Hypotension—Doxorubicin—hematologic cancer	1.89e-05	0.000135	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.89e-05	0.000135	CcSEcCtD
Mifepristone—Fatigue—Epirubicin—hematologic cancer	1.89e-05	0.000135	CcSEcCtD
Mifepristone—Pain—Epirubicin—hematologic cancer	1.87e-05	0.000133	CcSEcCtD
Mifepristone—Constipation—Epirubicin—hematologic cancer	1.87e-05	0.000133	CcSEcCtD
Mifepristone—Urticaria—Methotrexate—hematologic cancer	1.86e-05	0.000132	CcSEcCtD
Mifepristone—Dizziness—Prednisone—hematologic cancer	1.85e-05	0.000132	CcSEcCtD
Mifepristone—Abdominal pain—Methotrexate—hematologic cancer	1.85e-05	0.000132	CcSEcCtD
Mifepristone—Body temperature increased—Methotrexate—hematologic cancer	1.85e-05	0.000132	CcSEcCtD
Mifepristone—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.84e-05	0.000132	CcSEcCtD
Mifepristone—Insomnia—Doxorubicin—hematologic cancer	1.83e-05	0.000131	CcSEcCtD
Mifepristone—Dyspnoea—Doxorubicin—hematologic cancer	1.8e-05	0.000129	CcSEcCtD
Mifepristone—Feeling abnormal—Epirubicin—hematologic cancer	1.8e-05	0.000129	CcSEcCtD
Mifepristone—Somnolence—Doxorubicin—hematologic cancer	1.8e-05	0.000128	CcSEcCtD
Mifepristone—Gastrointestinal pain—Epirubicin—hematologic cancer	1.79e-05	0.000128	CcSEcCtD
Mifepristone—Vomiting—Prednisone—hematologic cancer	1.78e-05	0.000127	CcSEcCtD
Mifepristone—Rash—Prednisone—hematologic cancer	1.76e-05	0.000126	CcSEcCtD
Mifepristone—Dermatitis—Prednisone—hematologic cancer	1.76e-05	0.000126	CcSEcCtD
Mifepristone—Decreased appetite—Doxorubicin—hematologic cancer	1.76e-05	0.000126	CcSEcCtD
Mifepristone—Headache—Prednisone—hematologic cancer	1.75e-05	0.000125	CcSEcCtD
Mifepristone—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.75e-05	0.000125	CcSEcCtD
Mifepristone—Fatigue—Doxorubicin—hematologic cancer	1.74e-05	0.000124	CcSEcCtD
Mifepristone—Urticaria—Epirubicin—hematologic cancer	1.74e-05	0.000124	CcSEcCtD
Mifepristone—Constipation—Doxorubicin—hematologic cancer	1.73e-05	0.000123	CcSEcCtD
Mifepristone—Pain—Doxorubicin—hematologic cancer	1.73e-05	0.000123	CcSEcCtD
Mifepristone—Abdominal pain—Epirubicin—hematologic cancer	1.73e-05	0.000123	CcSEcCtD
Mifepristone—Body temperature increased—Epirubicin—hematologic cancer	1.73e-05	0.000123	CcSEcCtD
Mifepristone—Hypersensitivity—Methotrexate—hematologic cancer	1.72e-05	0.000123	CcSEcCtD
Mifepristone—Asthenia—Methotrexate—hematologic cancer	1.68e-05	0.00012	CcSEcCtD
Mifepristone—Feeling abnormal—Doxorubicin—hematologic cancer	1.67e-05	0.000119	CcSEcCtD
Mifepristone—Nausea—Prednisone—hematologic cancer	1.66e-05	0.000119	CcSEcCtD
Mifepristone—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.65e-05	0.000118	CcSEcCtD
Mifepristone—Pruritus—Methotrexate—hematologic cancer	1.65e-05	0.000118	CcSEcCtD
Mifepristone—Hypersensitivity—Epirubicin—hematologic cancer	1.61e-05	0.000115	CcSEcCtD
Mifepristone—Urticaria—Doxorubicin—hematologic cancer	1.61e-05	0.000115	CcSEcCtD
Mifepristone—Abdominal pain—Doxorubicin—hematologic cancer	1.6e-05	0.000114	CcSEcCtD
Mifepristone—Body temperature increased—Doxorubicin—hematologic cancer	1.6e-05	0.000114	CcSEcCtD
Mifepristone—Diarrhoea—Methotrexate—hematologic cancer	1.6e-05	0.000114	CcSEcCtD
Mifepristone—Asthenia—Epirubicin—hematologic cancer	1.57e-05	0.000112	CcSEcCtD
Mifepristone—Pruritus—Epirubicin—hematologic cancer	1.55e-05	0.00011	CcSEcCtD
Mifepristone—Dizziness—Methotrexate—hematologic cancer	1.55e-05	0.00011	CcSEcCtD
Mifepristone—Diarrhoea—Epirubicin—hematologic cancer	1.5e-05	0.000107	CcSEcCtD
Mifepristone—Hypersensitivity—Doxorubicin—hematologic cancer	1.49e-05	0.000106	CcSEcCtD
Mifepristone—Vomiting—Methotrexate—hematologic cancer	1.49e-05	0.000106	CcSEcCtD
Mifepristone—Rash—Methotrexate—hematologic cancer	1.47e-05	0.000105	CcSEcCtD
Mifepristone—Dermatitis—Methotrexate—hematologic cancer	1.47e-05	0.000105	CcSEcCtD
Mifepristone—Headache—Methotrexate—hematologic cancer	1.46e-05	0.000104	CcSEcCtD
Mifepristone—Asthenia—Doxorubicin—hematologic cancer	1.45e-05	0.000104	CcSEcCtD
Mifepristone—Dizziness—Epirubicin—hematologic cancer	1.45e-05	0.000103	CcSEcCtD
Mifepristone—Pruritus—Doxorubicin—hematologic cancer	1.43e-05	0.000102	CcSEcCtD
Mifepristone—Vomiting—Epirubicin—hematologic cancer	1.39e-05	9.92e-05	CcSEcCtD
Mifepristone—Nausea—Methotrexate—hematologic cancer	1.39e-05	9.9e-05	CcSEcCtD
Mifepristone—Diarrhoea—Doxorubicin—hematologic cancer	1.38e-05	9.88e-05	CcSEcCtD
Mifepristone—Rash—Epirubicin—hematologic cancer	1.38e-05	9.84e-05	CcSEcCtD
Mifepristone—Dermatitis—Epirubicin—hematologic cancer	1.38e-05	9.83e-05	CcSEcCtD
Mifepristone—Headache—Epirubicin—hematologic cancer	1.37e-05	9.78e-05	CcSEcCtD
Mifepristone—Dizziness—Doxorubicin—hematologic cancer	1.34e-05	9.55e-05	CcSEcCtD
Mifepristone—Nausea—Epirubicin—hematologic cancer	1.3e-05	9.27e-05	CcSEcCtD
Mifepristone—Vomiting—Doxorubicin—hematologic cancer	1.29e-05	9.18e-05	CcSEcCtD
Mifepristone—Rash—Doxorubicin—hematologic cancer	1.28e-05	9.1e-05	CcSEcCtD
Mifepristone—Dermatitis—Doxorubicin—hematologic cancer	1.27e-05	9.1e-05	CcSEcCtD
Mifepristone—Headache—Doxorubicin—hematologic cancer	1.27e-05	9.04e-05	CcSEcCtD
Mifepristone—Nausea—Doxorubicin—hematologic cancer	1.2e-05	8.58e-05	CcSEcCtD
Mifepristone—CYP3A7—Metabolism—GSTP1—hematologic cancer	4.55e-06	7.23e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SPHK1—hematologic cancer	4.52e-06	7.18e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTPN11—hematologic cancer	4.48e-06	7.12e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GBA—hematologic cancer	4.41e-06	7.02e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC35B2—hematologic cancer	4.41e-06	7.02e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—IDH1—hematologic cancer	4.4e-06	6.99e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BAD—hematologic cancer	4.39e-06	6.97e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK14—hematologic cancer	4.37e-06	6.95e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—TXN—hematologic cancer	4.35e-06	6.91e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCC3—hematologic cancer	4.35e-06	6.91e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTO1—hematologic cancer	4.35e-06	6.91e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NOTCH1—hematologic cancer	4.34e-06	6.91e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—UGT1A1—hematologic cancer	4.34e-06	6.9e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREB1—hematologic cancer	4.34e-06	6.9e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ABCB1—hematologic cancer	4.31e-06	6.84e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—ESR1—hematologic cancer	4.29e-06	6.81e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—BRAF—hematologic cancer	4.28e-06	6.81e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SPHK1—hematologic cancer	4.26e-06	6.77e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD80—hematologic cancer	4.26e-06	6.77e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	4.25e-06	6.76e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KIT—hematologic cancer	4.25e-06	6.75e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCL2—hematologic cancer	4.25e-06	6.75e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—MTHFR—hematologic cancer	4.23e-06	6.73e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6R—hematologic cancer	4.23e-06	6.73e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CREBBP—hematologic cancer	4.23e-06	6.72e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SLC22A1—hematologic cancer	4.22e-06	6.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CRABP1—hematologic cancer	4.22e-06	6.71e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—NCOR1—hematologic cancer	4.18e-06	6.64e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—GSTM1—hematologic cancer	4.18e-06	6.64e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTPN11—hematologic cancer	4.17e-06	6.64e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—NOTCH1—hematologic cancer	4.14e-06	6.59e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALOX5—hematologic cancer	4.11e-06	6.54e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	4.11e-06	6.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—UGT1A1—hematologic cancer	4.09e-06	6.5e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREB1—hematologic cancer	4.04e-06	6.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTAP—hematologic cancer	4.04e-06	6.42e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAP2K1—hematologic cancer	4.03e-06	6.41e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CD—hematologic cancer	4.01e-06	6.37e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—BRAF—hematologic cancer	3.99e-06	6.35e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NUP98—hematologic cancer	3.98e-06	6.33e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CRABP1—hematologic cancer	3.98e-06	6.32e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SLC22A1—hematologic cancer	3.98e-06	6.32e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MAPK3—hematologic cancer	3.97e-06	6.3e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6R—hematologic cancer	3.94e-06	6.27e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NQO1—hematologic cancer	3.94e-06	6.27e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CD44—hematologic cancer	3.94e-06	6.27e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CREBBP—hematologic cancer	3.94e-06	6.26e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALOX5—hematologic cancer	3.88e-06	6.16e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ADCY7—hematologic cancer	3.87e-06	6.15e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOA3—hematologic cancer	3.87e-06	6.15e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—MYC—hematologic cancer	3.86e-06	6.13e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NUP214—hematologic cancer	3.84e-06	6.11e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—FGF2—hematologic cancer	3.84e-06	6.1e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3R1—hematologic cancer	3.78e-06	6.01e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTR—hematologic cancer	3.76e-06	5.98e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ABCG2—hematologic cancer	3.76e-06	5.98e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAP2K1—hematologic cancer	3.76e-06	5.98e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—CREBBP—hematologic cancer	3.76e-06	5.97e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NUP98—hematologic cancer	3.75e-06	5.97e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CD—hematologic cancer	3.73e-06	5.94e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	3.73e-06	5.93e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CYCS—hematologic cancer	3.73e-06	5.93e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—HSP90AA1—hematologic cancer	3.71e-06	5.89e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—MTHFR—hematologic cancer	3.69e-06	5.87e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ENO2—hematologic cancer	3.69e-06	5.87e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JAK2—hematologic cancer	3.68e-06	5.85e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ADCY7—hematologic cancer	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOA3—hematologic cancer	3.64e-06	5.79e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NUP214—hematologic cancer	3.62e-06	5.75e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—FHL2—hematologic cancer	3.6e-06	5.72e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MDM2—hematologic cancer	3.59e-06	5.71e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTT1—hematologic cancer	3.58e-06	5.69e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—FGF2—hematologic cancer	3.58e-06	5.68e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CG—hematologic cancer	3.56e-06	5.66e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCG2—hematologic cancer	3.55e-06	5.64e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTR—hematologic cancer	3.55e-06	5.64e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AGRN—hematologic cancer	3.53e-06	5.61e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3R1—hematologic cancer	3.53e-06	5.61e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—SDC1—hematologic cancer	3.5e-06	5.56e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MTOR—hematologic cancer	3.49e-06	5.55e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CB—hematologic cancer	3.49e-06	5.55e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ENO2—hematologic cancer	3.48e-06	5.53e-05	CbGpPWpGaD
Mifepristone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	3.47e-06	5.52e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—JAK2—hematologic cancer	3.43e-06	5.45e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTT1—hematologic cancer	3.37e-06	5.36e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	3.35e-06	5.33e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MDM2—hematologic cancer	3.35e-06	5.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH2—hematologic cancer	3.34e-06	5.32e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HMMR—hematologic cancer	3.34e-06	5.32e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—CREBBP—hematologic cancer	3.3e-06	5.24e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—SDC1—hematologic cancer	3.3e-06	5.24e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTP1—hematologic cancer	3.29e-06	5.23e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1B—hematologic cancer	3.28e-06	5.21e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CB—hematologic cancer	3.26e-06	5.18e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MTOR—hematologic cancer	3.26e-06	5.18e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CD4—hematologic cancer	3.25e-06	5.17e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CASP3—hematologic cancer	3.21e-06	5.11e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL2—hematologic cancer	3.21e-06	5.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ARNTL—hematologic cancer	3.14e-06	5e-05	CbGpPWpGaD
Mifepristone—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	3.14e-06	4.99e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CD—hematologic cancer	3.13e-06	4.97e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CCND1—hematologic cancer	3.13e-06	4.97e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—JUN—hematologic cancer	3.12e-06	4.96e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ABCB1—hematologic cancer	3.11e-06	4.95e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CG—hematologic cancer	3.1e-06	4.93e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—ALB—hematologic cancer	3.09e-06	4.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ACP5—hematologic cancer	3.06e-06	4.86e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CA9—hematologic cancer	3.06e-06	4.86e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1B—hematologic cancer	3.06e-06	4.86e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—CDKN1A—hematologic cancer	3.02e-06	4.81e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MAPK3—hematologic cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—GSTM1—hematologic cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—NCOR1—hematologic cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOR2—hematologic cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PTEN—hematologic cancer	3.02e-06	4.8e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NQO1—hematologic cancer	2.97e-06	4.73e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CD44—hematologic cancer	2.97e-06	4.73e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3R1—hematologic cancer	2.95e-06	4.7e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK8—hematologic cancer	2.95e-06	4.69e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—MYC—hematologic cancer	2.94e-06	4.67e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—EP300—hematologic cancer	2.88e-06	4.58e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—CREBBP—hematologic cancer	2.88e-06	4.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—IDH1—hematologic cancer	2.88e-06	4.57e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTO1—hematologic cancer	2.84e-06	4.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—TXN—hematologic cancer	2.84e-06	4.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCC3—hematologic cancer	2.84e-06	4.52e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—CDKN1A—hematologic cancer	2.82e-06	4.48e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CYCS—hematologic cancer	2.81e-06	4.47e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PTEN—hematologic cancer	2.81e-06	4.47e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CD44—hematologic cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NQO1—hematologic cancer	2.8e-06	4.46e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—SRC—hematologic cancer	2.8e-06	4.45e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—HSP90AA1—hematologic cancer	2.8e-06	4.45e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SPHK1—hematologic cancer	2.78e-06	4.42e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CD—hematologic cancer	2.73e-06	4.34e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CB—hematologic cancer	2.73e-06	4.33e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—VEGFA—hematologic cancer	2.73e-06	4.33e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—STAT3—hematologic cancer	2.7e-06	4.29e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—ALB—hematologic cancer	2.69e-06	4.28e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—NRAS—hematologic cancer	2.69e-06	4.28e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—EP300—hematologic cancer	2.68e-06	4.26e-05	CbGpPWpGaD
Mifepristone—PGR—Gene Expression—AKT1—hematologic cancer	2.68e-06	4.25e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—UGT1A1—hematologic cancer	2.67e-06	4.25e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—MTHFR—hematologic cancer	2.67e-06	4.24e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CYCS—hematologic cancer	2.65e-06	4.22e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—HSP90AA1—hematologic cancer	2.64e-06	4.19e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—SRC—hematologic cancer	2.61e-06	4.15e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CRABP1—hematologic cancer	2.6e-06	4.13e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SLC22A1—hematologic cancer	2.6e-06	4.13e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MAPK3—hematologic cancer	2.58e-06	4.1e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3R1—hematologic cancer	2.58e-06	4.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALOX5—hematologic cancer	2.53e-06	4.03e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—STAT3—hematologic cancer	2.52e-06	4e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—NRAS—hematologic cancer	2.51e-06	3.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—MYC—hematologic cancer	2.51e-06	3.99e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TGFB1—hematologic cancer	2.5e-06	3.98e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTP1—hematologic cancer	2.48e-06	3.94e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NUP98—hematologic cancer	2.45e-06	3.9e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MAPK3—hematologic cancer	2.4e-06	3.82e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ADCY7—hematologic cancer	2.38e-06	3.79e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOA3—hematologic cancer	2.38e-06	3.79e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CB—hematologic cancer	2.38e-06	3.78e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NUP214—hematologic cancer	2.37e-06	3.76e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PTEN—hematologic cancer	2.36e-06	3.75e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—MYC—hematologic cancer	2.34e-06	3.72e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTP1—hematologic cancer	2.34e-06	3.72e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—TGFB1—hematologic cancer	2.33e-06	3.71e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTR—hematologic cancer	2.32e-06	3.69e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCG2—hematologic cancer	2.32e-06	3.69e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—KRAS—hematologic cancer	2.32e-06	3.68e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MAPK3—hematologic cancer	2.29e-06	3.64e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—NCOR1—hematologic cancer	2.28e-06	3.62e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—GSTM1—hematologic cancer	2.28e-06	3.62e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ENO2—hematologic cancer	2.27e-06	3.61e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—EP300—hematologic cancer	2.25e-06	3.57e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CG—hematologic cancer	2.24e-06	3.57e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—MYC—hematologic cancer	2.23e-06	3.54e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ABCB1—hematologic cancer	2.21e-06	3.52e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTT1—hematologic cancer	2.2e-06	3.51e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—KRAS—hematologic cancer	2.16e-06	3.43e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—SDC1—hematologic cancer	2.16e-06	3.43e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—NCOR1—hematologic cancer	2.15e-06	3.41e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—GSTM1—hematologic cancer	2.15e-06	3.41e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—PIK3CA—hematologic cancer	2.13e-06	3.38e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—CREBBP—hematologic cancer	2.08e-06	3.31e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—TP53—hematologic cancer	2.06e-06	3.27e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PTEN—hematologic cancer	2.05e-06	3.27e-05	CbGpPWpGaD
Mifepristone—AR—Gene Expression—AKT1—hematologic cancer	2.04e-06	3.24e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—MTHFR—hematologic cancer	2.01e-06	3.2e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—PIK3CA—hematologic cancer	1.98e-06	3.15e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CD—hematologic cancer	1.97e-06	3.13e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—HRAS—hematologic cancer	1.97e-06	3.13e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—EP300—hematologic cancer	1.96e-06	3.12e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—ALB—hematologic cancer	1.95e-06	3.09e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—MTHFR—hematologic cancer	1.9e-06	3.02e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—IL6—hematologic cancer	1.89e-06	3e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3R1—hematologic cancer	1.86e-06	2.96e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—HRAS—hematologic cancer	1.84e-06	2.92e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NQO1—hematologic cancer	1.83e-06	2.91e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CD44—hematologic cancer	1.83e-06	2.91e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—IL6—hematologic cancer	1.76e-06	2.79e-05	CbGpPWpGaD
Mifepristone—PGR—Signaling Pathways—AKT1—hematologic cancer	1.74e-06	2.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CYCS—hematologic cancer	1.73e-06	2.76e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—HSP90AA1—hematologic cancer	1.72e-06	2.74e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CB—hematologic cancer	1.72e-06	2.73e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CG—hematologic cancer	1.69e-06	2.69e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—PIK3CA—hematologic cancer	1.66e-06	2.64e-05	CbGpPWpGaD
Mifepristone—ABCC1—Disease—AKT1—hematologic cancer	1.62e-06	2.58e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CG—hematologic cancer	1.6e-06	2.54e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—CREBBP—hematologic cancer	1.57e-06	2.49e-05	CbGpPWpGaD
Mifepristone—NR3C1—Gene Expression—AKT1—hematologic cancer	1.55e-06	2.46e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTP1—hematologic cancer	1.53e-06	2.43e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CD—hematologic cancer	1.49e-06	2.37e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PTEN—hematologic cancer	1.49e-06	2.36e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—CREBBP—hematologic cancer	1.48e-06	2.35e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—ALB—hematologic cancer	1.47e-06	2.34e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—PIK3CA—hematologic cancer	1.45e-06	2.3e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ABCB1—hematologic cancer	1.45e-06	2.3e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—EP300—hematologic cancer	1.42e-06	2.25e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3R1—hematologic cancer	1.41e-06	2.23e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—GSTM1—hematologic cancer	1.4e-06	2.23e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—NCOR1—hematologic cancer	1.4e-06	2.23e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CD—hematologic cancer	1.4e-06	2.23e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—ALB—hematologic cancer	1.38e-06	2.2e-05	CbGpPWpGaD
Mifepristone—ABCC1—Metabolism—AKT1—hematologic cancer	1.36e-06	2.16e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3R1—hematologic cancer	1.32e-06	2.1e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CB—hematologic cancer	1.3e-06	2.06e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—MTHFR—hematologic cancer	1.24e-06	1.97e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CB—hematologic cancer	1.22e-06	1.94e-05	CbGpPWpGaD
Mifepristone—CYP3A7—Metabolism—AKT1—hematologic cancer	1.18e-06	1.88e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PTEN—hematologic cancer	1.12e-06	1.78e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—EP300—hematologic cancer	1.07e-06	1.7e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PTEN—hematologic cancer	1.06e-06	1.68e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—PIK3CA—hematologic cancer	1.05e-06	1.67e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CG—hematologic cancer	1.04e-06	1.66e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—EP300—hematologic cancer	1.01e-06	1.6e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—CREBBP—hematologic cancer	9.67e-07	1.54e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CD—hematologic cancer	9.17e-07	1.46e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—ALB—hematologic cancer	9.05e-07	1.44e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3R1—hematologic cancer	8.66e-07	1.38e-05	CbGpPWpGaD
Mifepristone—CYP3A5—Metabolism—AKT1—hematologic cancer	8.56e-07	1.36e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CB—hematologic cancer	7.99e-07	1.27e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—PIK3CA—hematologic cancer	7.91e-07	1.26e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—PIK3CA—hematologic cancer	7.45e-07	1.18e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PTEN—hematologic cancer	6.91e-07	1.1e-05	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—EP300—hematologic cancer	6.59e-07	1.05e-05	CbGpPWpGaD
Mifepristone—ABCB1—Metabolism—AKT1—hematologic cancer	6.46e-07	1.03e-05	CbGpPWpGaD
Mifepristone—CYP2D6—Metabolism—AKT1—hematologic cancer	6.09e-07	9.68e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—PIK3CA—hematologic cancer	4.87e-07	7.74e-06	CbGpPWpGaD
Mifepristone—CYP3A4—Metabolism—AKT1—hematologic cancer	3.98e-07	6.33e-06	CbGpPWpGaD
